Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


10.02.2025

1 BMJ
1 J Clin Psychiatry
3 J Clin Psychopharmacol
2 Mol Psychiatry
1 PLoS One
2 Psychiatry Res
6 Psychol Med
10 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. DYER C
    Valdo Calocane's dislike of needles left him unmedicated for schizophrenia, finds report.
    BMJ. 2025;388:r263.
    PubMed        


    J Clin Psychiatry

  2. RAMIREZ J, Correll CU
    Relationship Between Trauma, PTSD, and Schizophrenia: Relevance for Outcomes, Screening, and Interventions.
    J Clin Psychiatry. 2025;86:24ac15773.
    PubMed        


    J Clin Psychopharmacol

  3. DODDI SR, Pham F, Wineke J, Marano C, et al
    Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination: A Case Report.
    J Clin Psychopharmacol. 2025 Feb 10. doi: 10.1097/JCP.0000000000001969.
    PubMed        

  4. ELOMA-ATA A, Wafy F, Parikh A, Tusher A, et al
    A Case of Hypothermia Associated With the Use of Multiple Antipsychotics in a Patient With Late-Onset Schizophrenia.
    J Clin Psychopharmacol. 2025 Feb 7. doi: 10.1097/JCP.0000000000001961.
    PubMed        

  5. GOFF DC
    At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy).
    J Clin Psychopharmacol. 2025 Feb 6. doi: 10.1097/JCP.0000000000001959.
    PubMed        


    Mol Psychiatry

  6. DI RE J, Marini M, Hussain SI, Singh AK, et al
    betaIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophrenia.
    Mol Psychiatry. 2025 Feb 7. doi: 10.1038/s41380-025-02917.
    PubMed         Abstract available

  7. VINKE LN, Avanaki M, Jeffrey C, Harikumar A, et al
    Neural correlates of personal space regulation in psychosis: role of the inferior parietal cortex.
    Mol Psychiatry. 2025 Feb 3. doi: 10.1038/s41380-025-02906.
    PubMed         Abstract available


    PLoS One

  8. ZHAO R, Shi H, Wang Y, Jiang T, et al
    Allele-specific methylation of SSTR4 associated with aging and cognitive functions in patients with schizophrenia.
    PLoS One. 2025;20:e0303038.
    PubMed         Abstract available


    Psychiatry Res

  9. HWANG H, Kim SM, Kim HJ, Han DH, et al
    Comparison of attention and brain functional connectivity between patient groups with schizophrenia and attention deficit hyperactivity disorder.
    Psychiatry Res. 2025;345:116376.
    PubMed         Abstract available

  10. HUIZER K, Soni S, Schmidt MA, Cakici N, et al
    Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia.
    Psychiatry Res. 2025;345:116379.
    PubMed         Abstract available


    Psychol Med

  11. SARGENT K, Martinez E, Reed A, Guha A, et al
    Brain-body dysconnectivity: deficient autonomic regulation of cortical function in first-episode schizophrenia.
    Psychol Med. 2025;55:e1.
    PubMed         Abstract available

  12. SAPERIA S, Plahouras J, Best M, Kidd S, et al
    The cognitive model of negative symptoms: a systematic review and meta-analysis of the dysfunctional belief systems associated with negative symptoms in schizophrenia spectrum disorders.
    Psychol Med. 2025;55:e11.
    PubMed         Abstract available

  13. FERRARO L, Di Forti M, La Barbera D, La Cascia C, et al
    Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors.
    Psychol Med. 2025;55:e12.
    PubMed         Abstract available

  14. STRAUSS GP, Raugh I, Visser K, Walker E, et al
    Deconstructing the nature of emotion regulation impairments at the identification, selection, and implementation stages in individuals at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e22.
    PubMed         Abstract available

  15. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    Multidimensional outcome of first-episode psychosis: a network analysis.
    Psychol Med. 2025;55:e29.
    PubMed         Abstract available

  16. LUTHER L, Raugh IM, Strauss GP
    Probabalistic reinforcement learning impairments predict negative symptom severity and risk for conversion in youth at clinical high-risk for psychosis.
    Psychol Med. 2025;55:e28.
    PubMed         Abstract available


    Schizophr Res

  17. HAN S, Gilmartin M, Sheng W, Jin VX, et al
    Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes.
    Schizophr Res. 2025;276:205-213.
    PubMed         Abstract available

  18. HECHINGER RM, Javaras KN, Lewandowski KE
    Comorbidity of anorexia nervosa and schizophrenia: A systematic review.
    Schizophr Res. 2025;276:185-193.
    PubMed         Abstract available

  19. AGUIRRE JM, Diaz Dellarossa C, Barbagelata D, Vasquez J, et al
    Cognitive function at first episode in patients subsequently developing treatment-resistant schizophrenia.
    Schizophr Res. 2025;276:178-184.
    PubMed         Abstract available

  20. LIU L, Xia Y, Chen L, Zou F, et al
    Binaural hearing impairment in patients with schizophrenia: A multicenter study.
    Schizophr Res. 2025;276:175-177.
    PubMed        

  21. KEMP KC, Tso IF, Taylor SF, Moe AM, et al
    Social stress in schizophrenia: Unique contributions to social cognition and social functioning.
    Schizophr Res. 2025;276:167-174.
    PubMed         Abstract available

  22. ERESHEFSKY S, Gemignani R, Savill M, Sanford KC, et al
    A mixed-methods study exploring the benefits, drawbacks, and utilization of data in care: Findings from the EPI-CAL early psychosis learning health care network.
    Schizophr Res. 2025;276:157-166.
    PubMed         Abstract available

  23. SHARMA D, Bharadaj SK, Bharadaj S, Chakraborty S, et al
    MicroRNA-regulated suppression of some overexpressed genes in schizophrenia and their evolutionary significance.
    Schizophr Res. 2025;276:143-156.
    PubMed         Abstract available

  24. DELAY C, Link P, Holden J, Granholm E, et al
    Using pupillometry to predict outcome in cognitive behavioral therapy for negative symptoms of schizophrenia.
    Schizophr Res. 2025;276:135-142.
    PubMed         Abstract available

  25. DE WITH J, van der Pluijm M, de Haan L, Schirmbeck F, et al
    The role of the behavioural inhibition and activation system in the association between attachment style and positive or negative symptoms in patients with psychosis and unaffected siblings.
    Schizophr Res. 2025;276:127-134.
    PubMed         Abstract available

  26. HARVEY PD, Kaul I, Chataverdi S, Patel T, et al
    Capturing changes in social functioning and positive affect using ecological momentary assessment during a 12-month trial of xanomeline and trospium chloride in schizophrenia.
    Schizophr Res. 2025;276:117-126.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.